2021 Asian Pacific Society of Cardiology Consensus Recommendations on the Use of P2Y1(2) Receptor Antagonists in the Asia-Pacific Region: Special Populations

Advanced age, diabetes, and chronic kidney disease not only increase the risk for ischaemic events in chronic coronary syndromes (CCS) but also confer a high bleeding risk during antiplatelet therapy. These special populations may warrant modification of therapy, especially among Asians, who have di...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Jack Wei Chieh, Chew, Derek P, Tsui, Kin Lam, Tan, Doreen, Duplyakov, Dmitry, Hammoudeh, Ayman, Zhang, Bo, Li, Yi, Xu, Kai, Ong, Paul J, Firman, Doni, Gamra, Habib, Almahmeed, Wael, Dalal, Jamshed, Tam, Li-Wah, Steg, Gabriel, Nguyen, Quang N, Ako, Junya, Al Suwaidi, Jassim, Chan, Mark, Sobhy, Mohamed, Shehab, Abdulla, Buddhari, Wacin, Wang, Zulu, Fong, Alan Yean Yip, Karadag, Bilgehan, Kim, Byeong-Keuk, Baber, Usman, Chin, Chee Tang, Han, Ya Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2021
Materias:
APSC Consensus Recommendations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591619/
https://www.ncbi.nlm.nih.gov/pubmed/34815751
http://dx.doi.org/10.15420/ecr.2021.35

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591619/
https://www.ncbi.nlm.nih.gov/pubmed/34815751
http://dx.doi.org/10.15420/ecr.2021.35

Ejemplares similares